Anticipating immuno-oncology modality/platform development trends for 2022

IMMUNO-ONCOLOGY INSIGHTS

Anticipating immuno-oncology modality/platform development trends for 2022

January 2022
Anticipating immuno-oncology modality/platform development trends for 2022
Download PDF

Expert Insight

A need to update paradigms for myeloid cells within the tumor microenvironment to advance immunotherapy

A need to update paradigms for myeloid cells within the tumor microenvironment to advance immunotherapy

Michelle Kinder, PhD
21 January 2022
Read

Innovator Insight

Advancing engineered cell & gene therapy with precision gene editing

Advancing engineered cell & gene therapy with precision gene editing

John Lambourne
26 January 2022
Read

Commentary

BCMA targeting CAR T cells using a novel D-domain binder for multiple myeloma: clinical development update

BCMA targeting CAR T cells using a novel D-domain binder for multiple myeloma: clinical development update

A Rotte, C Heery, B Gliner et al.
24 January 2022
Read

Interview

Leveraging LAG-3 for improved patient outcomes

Leveraging LAG-3 for improved patient outcomes

Paul Basciano
24 January 2022
Read
Realizing the potential of NK cell therapy

Realizing the potential of NK cell therapy

Alvin Shih
24 January 2022
Read